The number that traveled around the internet this summer was striking: people who ate the most chili peppers had nearly three times the odds of developing esophageal cancer compared with people who ate the least. It came from a real meta-analysis, published in a real journal, and it is being reported accurately.
What it is not is new. The analysis appeared in November 2022. It resurfaced on July 14 when ScienceDaily recirculated it, and a wave of coverage followed. The detail almost nobody mentioned sits one line above the headline figure.
Fourteen Case-Control Studies, One of Them from 1987
When the researchers pooled all gastrointestinal cancers, their summary estimate was an odds ratio of 1.64, with a 95% confidence interval of 1.00 to 2.70. The lower bound is exactly 1.00, which means no association at all. That is a result balanced on a knife-edge, and it comes from a body of evidence with an unusual problem: the direction of the effect reverses depending on which continent the study was run in.
The analysis, published in Frontiers in Nutrition by Changchang Chen and colleagues, with corresponding author Hongjuan Lang of the Fourth Military Medical University in Xi'an, screened more than 11,000 records and kept 14. All 14 were case-control studies, involving 5,009 gastrointestinal cancers among 11,310 participants. Publication years spanned 1987 to 2021.
Case-control designs recruit people who already have cancer and ask them what they used to eat. That structure invites recall bias, and it cannot establish that the food came before the disease. There were no cohort studies and no randomized data. Heterogeneity was extreme, with an I-squared value of 90.3%, indicating that the studies disagreed with each other far more than chance would explain.
The esophageal signal was the strongest finding, with a pooled odds ratio of 2.71. For stomach cancer, the association was not statistically significant. For colorectal cancer, the pooled estimate pointed the other way, also without reaching significance. The authors concluded that chili pepper "is a risk factor for certain GI cancers," while listing residual confounding, recall bias, and the absence of dose-response analysis among their own limitations.
The Result Reverses When You Cross an Ocean
Stratifying by region produced the most awkward finding in the paper. Studies from Asia showed an odds ratio of 2.50. North American studies showed 2.61. African studies showed 1.62. But South American studies showed 0.50, and European studies showed 0.30. In those populations, the highest chili intake was associated with substantially lower gastrointestinal cancer risk.
The authors offer a plausible explanation. Estimated daily capsaicin intake in Europe is roughly 1.5 milligrams, against 25 to 200 milligrams per person daily in parts of Asia and North America. They raise the possibility of a U-shaped curve, in which modest intake is protective and heavy intake is not. They also stress that outside Asia, each region contributed only one or two studies, and that the subgroup numbers should be read cautiously.
The Confounder Sitting Next to the Peppers
There is a well-established carcinogen that travels with spicy cuisine in several of the regions studied, and it is temperature.
In 2016, the International Agency for Research on Cancer classified drinking very hot beverages, defined as above 65 degrees Celsius, as probably carcinogenic to humans. The evidence came largely from China, Iran, Turkey, and South America, where tea or maté is traditionally drunk at around 70 degrees, and where esophageal cancer rates are high. IARC was explicit that temperature, rather than the drinks themselves, appears to be responsible. That evidence base rests mainly on squamous cell carcinoma, the same subtype that dominates in the regions where most clinical studies were conducted.
A prospective analysis of 454,796 UK Biobank participants, published in the British Journal of Cancer, later found a higher risk of squamous cell carcinoma among people who preferred hot or very hot drinks, with risk increasing as daily intake rose.
None of the 14 chili studies measured food or drink temperature. Only one reported Helicobacter pylori status, despite that infection being a major gastrointestinal cancer risk factor. Smoking was adjusted for in eight, alcohol in six.
The Cohort Data Point the Opposite Way
The strongest human evidence on spicy food and health outcomes is not a case-control study. In 2015, researchers using the China Kadoorie Biobank followed 487,375 adults aged 30 to 79 for a median of 7.2 years, excluding anyone with cancer, heart disease or stroke at baseline. Published in The BMJ, the analysis found people eating spicy food one or two days a week had a 10 percent lower risk of death than those eating it less than weekly, and those eating it three or more days a week had a 14 percent lower risk.
That study measured mortality, not esophageal cancer incidence, and it is observational as well. But it is prospective, an order of magnitude larger, and it points in the opposite direction from the meta-analysis headline.
The limitations across this evidence base are serious enough to state directly. Every chili-cancer estimate here comes from retrospective case-control research with self-reported diets, no dose-response modeling, no temperature data, unmeasured infection status, and heterogeneity so high that the pooled figure is arguably not interpretable as a single number. Esophageal cancer remains a lethal disease usually found late, according to National Cancer Institute surveillance data, and the established drivers are tobacco, heavy alcohol, reflux, and obesity. No major cancer organization advises avoiding chili peppers. Anyone with persistent swallowing difficulty, unexplained weight loss, or food sticking in the throat should see a clinician, regardless of what is in their hot sauce.
Key Questions Answered
Do chili peppers cause cancer?
No study here shows that. The research is observational and can only describe associations, several of which run in the opposite direction depending on the population studied.
How strong is the headline number?
The pooled gastrointestinal estimate had a confidence interval whose lower bound touched 1.00, the point of no association. The esophageal subgroup estimate was stronger and more consistent.
Is this new research?
No. The meta-analysis was published in November 2022. It returned to circulation in July 2026 after being recirculated by a science news aggregator.
Why do European studies show the opposite result?
Estimated capsaicin intake in Europe is far lower than in Asia or Mexico, so the highest-intake European group may sit at a dose that is not comparable. With only two European studies, the finding is fragile.
What does temperature have to do with it?
IARC classified very hot beverages above 65 degrees Celsius as probably carcinogenic to the esophagus. None of the chili studies recorded how hot the food or drink was, leaving a plausible confounder unmeasured.
Has any large cohort study linked spicy food to harm?
The largest prospective analysis, covering 487,375 Chinese adults, found that regular spicy food consumption was associated with lower, not higher, total mortality.
Who is genuinely at elevated risk of esophageal cancer?
Established risk factors include tobacco use, heavy alcohol consumption, chronic reflux, and obesity. Screening decisions belong with a physician.
